The presence of HER2 mutations in NSCLC is correlated with a “cold” tumor microenvironment, characterized by a relatively lower PD-L1 positive expression rate and tumor mutation burden (TMB), similar to those of EGFR-dependent tumors (90, 91). This evidence concerns the gene EGFR and neoplasm.